Superbug drugs firm backs takeover by Novartis
A biotech firm involved in developing drugs for fighting hospital superbugs today backed a £305m (€444m) takeover by pharmaceuticals giant Novartis.
The proposed deal for NeuTec Pharma will earn windfalls for the couple who set up the business at the University of Manchester less than 10 years ago.





